A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head
A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head
Active, not recruiting · NCT07471880 · Registry updated 2026-03-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head | Legg-Calve-Perthes disease, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone disorder, familial avascular necrosis of femoral head, musculoskeletal system disorder, osteonecrosis | Active, not recruiting | Phase 2 | 2026-03-24 | NCT07471880 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. | Zhongshan | China | 1 |